Sign in
4

Changes in Ownership

RenovoRx, Inc. Filed Acc 0001209191-22-055815

Director acquired 25,438 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Marton Laurence Director 2022-11-03 Option exercise +25,438 $1.70 $43,245 25,438 D
Derivatives
Marton Laurence Director 2022-11-03 Option exercise · Stock Option (right to buy) −25,438 0 D
Loading xslF345X03/doc4.xml…